
|Videos|July 23, 2018
How Can Specialty Pharmacies Prepare for New Orphan Drugs?
Joy Gilbert, vice president of operations at US Bioservices, gives advice about how specialty pharmacies need to prepare for new drug approvals.
Advertisement
Joy Gilbert, vice president of operations at US Bioservices, a part of AmerisourceBergen, gives advice about how specialty pharmacies need to prepare for new drug approvals.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Polycystic Ovary Syndrome Undergoes Name Change: Polyendocrine Metabolic Ovarian Syndrome
2
Amid Mounting Pressure, FDA Commissioner Marty Makary Resigns
3
GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer
4
Sonrotoclax Approval Delivers a Long-Awaited New Option for Relapsed or Refractory Mantle Cell Lymphoma
5


































































































































